|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Expenses | |||||
| Research and development | |||||
| General and administrative expenses | |||||
| Share-based compensation | |||||
| Total Operating Expenses | |||||
| Loss from operations | |||||
| Other expenses, net | |||||
| Financial expense, net | |||||
| Gain on retirement of royalty accrual | |||||
| Registration Rights Agreement expense | |||||
| Convertible promissory note discount amortization | |||||
| Total other expenses, net | |||||
| Loss before provision for income taxes | |||||
| Net loss | |||||
| Net loss per common share | |||||
| Net loss per common share, Basic (in Dollars per share) | |||||
| Net loss per common share, Diluted (in Dollars per share) | |||||
| Weighted-average common shares outstanding | |||||
| Weighted-average common shares outstanding, Basic (in Shares) | |||||
| Weighted-average common shares outstanding, Diluted (in Shares) | |||||
Loading...